Protease-Activated Receptor-3 (PAR-3) (1-6), human (TFA)

• UNSPSC Description:

  Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA is a proteinase-activated receptor (PAR-3) agonist peptide[1].

• Target Antigen:

  Protease Activated Receptor (PAR)

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/protease-activated-receptor-3-par-3-1-6-human-tfa.html

• Purity:

  99.86

• Solubility:

  H2O : 100 mg/mL (ultrasonic)

• Smiles:

  O=C([C@@H](N)[C@@H](C)O)N[C@H](C(N[C@H](C(NCC(N[C@H](C(N1[C@H](C(N)=O)CCC1)=O)C)=O)=O)CCCNC(N)=N)=O)CC2=CC=CC=C2.O=C(O)C(F)(F)F

• Molecular Weight:

  760.76

• References & Citations:

  [1]inase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein. Pancreas. 2014 Jan; 43(1): 10.1097/MPA.0b013e31829f0b81.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported